In the last 12 months, insiders at OSR Holdings, Inc. ($OSRH) filed 43 transactions with the SEC: 2 open-market purchases totaling $20 and 0 sales totaling $0. Net insider sentiment: net buying.
OSR Holdings, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Hwang Kuk Hyoun (Chief Executive Officer) — 15 transactions totaling $4,300,010
- Bellevue Global Life Science Investors LLC (TenPercentOwner) — 12 transactions totaling $4,300,010
- REED STEVEN (Director) — 2 transactions totaling $0
- Yoo David Jin (Chief Financial Officer) — 2 transactions totaling $0
- Hwang Kuk Hyoun (President and CEO) — 3 transactions totaling $0
View all SEC Filings for OSR Holdings, Inc. (OSRH).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 43000 | $0.00 | 2,043,500.0000 | 4,481,692 | 2.15% | 0.96% |
| Feb. 14, 2025 | Hwang Kuk Hyoun | President and CEO | J | Common Stock | 43000 | $0.00 | 24,317,738.0000 | 4,481,692 | 0.18% | 0.96% |
| Feb. 14, 2025 | Hwang Kuk Hyoun | President and CEO | J | Common Stock | 7531634 | $0.00 | 24,317,738.0000 | 4,481,692 | 44.87% | 100.00% |
| Feb. 14, 2025 | Hwang Kuk Hyoun | President and CEO | J | Common Stock | 3123970 | $0.00 | 24,317,738.0000 | 4,481,692 | 14.74% | 69.71% |
| March 23, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 20000 | $0.00 | 2,000,500.0000 | 1,500,000 | 0.99% | 1.33% |
| March 23, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Warrant for Common Stock | 20000 | $0.00 | 370,000.0000 | 1,500,000 | 5.13% | 1.33% |
| March 23, 2023 | Yoo David Jin | Chief Financial Officer | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| March 23, 2023 | Yoo David Jin | Chief Financial Officer | A | Warrant for Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| March 23, 2023 | Bellevue Global Life Science Investors LLC | Not found | J | Common Stock | 20000 | $0.00 | 2,000,500.0000 | 1,500,000 | 0.99% | 1.33% |
| March 23, 2023 | Bellevue Global Life Science Investors LLC | Not found | J | Warrant for Common Stock | 20000 | $0.00 | 370,000.0000 | 1,500,000 | 5.13% | 1.33% |
| Feb. 21, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 225000 | $0.00 | 2,025,000.0000 | 1,500,000 | 12.50% | 15.00% |
| Feb. 21, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 4500 | $0.00 | 2,020,500.0000 | 1,500,000 | 0.22% | 0.30% |
| Feb. 21, 2023 | Bellevue Global Life Science Investors LLC | Not found | J | Common Stock | 225000 | $0.00 | 2,025,000.0000 | 1,500,000 | 12.50% | 15.00% |
| Feb. 21, 2023 | Bellevue Global Life Science Investors LLC | Not found | J | Common Stock | 4500 | $0.00 | 2,020,500.0000 | 1,500,000 | 0.22% | 0.30% |
| Feb. 14, 2023 | REED STEVEN | Director | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| Feb. 14, 2023 | REED STEVEN | Director | A | Warrant for Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| Feb. 14, 2023 | Chung In Chul | Director | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| Feb. 14, 2023 | Chung In Chul | Director | A | Warrant for Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| Feb. 14, 2023 | Roberts Rad | Director | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| Feb. 14, 2023 | Park Jin Whan | Director | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| Feb. 14, 2023 | Euh Hosun | Director | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 1,500,000 | 9999.99% | 1.33% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 20000 | $0.00 | 1,705,000.0000 | 1,500,000 | 1.16% | 1.33% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 20000 | $0.00 | 1,685,000.0000 | 1,500,000 | 1.17% | 1.33% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 20000 | $0.00 | 1,665,000.0000 | 1,500,000 | 1.19% | 1.33% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 20000 | $0.00 | 1,645,000.0000 | 1,500,000 | 1.20% | 1.33% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 20000 | $0.00 | 1,625,000.0000 | 1,500,000 | 1.22% | 1.33% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 225000 | $0.00 | 1,400,000.0000 | 1,500,000 | 13.85% | 15.00% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Common Stock | 30000 | $0.00 | 1,370,000.0000 | 1,500,000 | 2.14% | 2.00% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | A | Common Stock | 430000 | $10.00 | 1,800,000.0000 | 1,500,000 | 31.39% | 28.67% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | P | Private Placement Warrants | 430000 | $10.00 | 430,000.0000 | 1,500,000 | 9999.99% | 28.67% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Warrant for Common Stock | 20000 | $0.00 | 410,000.0000 | 1,500,000 | 4.65% | 1.33% |
| Feb. 14, 2023 | Bellevue Global Life Science Investors LLC | TenPercentOwner | J | Warrant for Common Stock | 20000 | $0.00 | 390,000.0000 | 1,500,000 | 4.88% | 1.33% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 20000 | $0.00 | 1,705,000.0000 | 1,500,000 | 1.16% | 1.33% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 20000 | $0.00 | 1,685,000.0000 | 1,500,000 | 1.17% | 1.33% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 20000 | $0.00 | 1,665,000.0000 | 1,500,000 | 1.19% | 1.33% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 20000 | $0.00 | 1,645,000.0000 | 1,500,000 | 1.20% | 1.33% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 20000 | $0.00 | 1,625,000.0000 | 1,500,000 | 1.22% | 1.33% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 225000 | $0.00 | 1,400,000.0000 | 1,500,000 | 13.85% | 15.00% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Common Stock | 30000 | $0.00 | 1,370,000.0000 | 1,500,000 | 2.14% | 2.00% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | A | Common Stock | 430000 | $10.00 | 1,800,000.0000 | 1,500,000 | 31.39% | 28.67% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | P | Private Placement Warrants | 430000 | $10.00 | 430,000.0000 | 1,500,000 | 9999.99% | 28.67% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Warrant for Common Stock | 20000 | $0.00 | 410,000.0000 | 1,500,000 | 4.65% | 1.33% |
| Feb. 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer | J | Warrant for Common Stock | 20000 | $0.00 | 390,000.0000 | 1,500,000 | 4.88% | 1.33% |